Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 20:55 UTC 7 1 comments 📋 Watson David O. (Officer) plans to sell 6K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $128K) Filed: Jan 13, 2026 | ID: 000283 Comment Full text
Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 20:53 UTC 8 1 comments 📋 DeLong Mark Jeffrey (Officer) plans to sell 2K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $39K) Filed: Jan 13, 2026 | ID: 000282 Comment Full text
Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 20:48 UTC 8 1 comments 📋 Deschatelets Pascal (Officer) plans to sell 2K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $51K) Filed: Jan 13, 2026 | ID: 000281 Comment Full text
Briacell Therapeutics Corp (BCTX) Business News Jan. 13, 2026, 20:48 UTC 3 1 comments Notification from BriaCell Therapeutics Corp. Market reaction Comment Full text
Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 20:45 UTC 8 1 comments 📋 Francois Cedric (Officer) plans to sell 10K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $226K) Filed: Jan 13, 2026 | ID: 000280 Comment Full text
Apellis Pharmaceuticals Inc (APLS) SEC News Jan. 13, 2026, 20:40 UTC 5 1 comments 📋 Sullivan Timothy Eugene (Officer) plans to sell 4K shares of Apellis Pharmaceuticals, Inc. (at $22.19 each, total $86K) Filed: Jan 13, 2026 | ID: 000278 Comment Full text
EDAP TMS S.A. (EDAP) SEC News Jan. 13, 2026, 20:32 UTC 5 0 comments New Form 3 - EDAP TMS SA Filed: 2026-01-13 AccNo: 0001829126-26-000279 Size: 16 KB Comment Full text
EDAP TMS S.A. (EDAP) SEC News Jan. 13, 2026, 20:28 UTC 5 0 comments New Form 3 - EDAP TMS SA Filed: 2026-01-13 AccNo: 0001829126-26-000278 Size: 21 KB Comment Full text
Lexaria Bioscience Corp. (LEXX) Event Jan. 13, 2026, 20:20 UTC 1 1 comments Lexaria Bioscience Corp. (LEXX) Files Form 10-Q Comment Full text
Co-Diagnostics Inc (CODX) Technical Exchange News Jan. 13, 2026, 19:54 UTC 10 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Clene Inc. (CLNNW) SEC News Jan. 13, 2026, 19:48 UTC 4 1 comments Director MATLIN DAVID J 🟢 acquired 33.3K shares (2 derivative) of Clene Inc. (CLNN) at $6.50 Transaction Date: Jan 13, 2026 | Filing ID: 001170 Comment Full text
Twist Bioscience (TWST) SEC News Jan. 13, 2026, 19:46 UTC 4 1 comments 📋 Finn Patrick John (Officer) plans to sell 23K shares of Twist Bioscience Corp (at $40.00 each, total $931K) Filed: Jan 13, 2026 | ID: 000275 Comment Full text
Twist Bioscience (TWST) SEC News Jan. 13, 2026, 19:42 UTC 2 1 comments 📋 Laponis Adam (Officer) plans to sell 3K shares of Twist Bioscience Corp (at $40.00 each, total $120K) Filed: Jan 13, 2026 | ID: 000274 Comment Full text
Entero Therapeutics Inc. (ENTO) SEC News Jan. 13, 2026, 19:13 UTC 3 0 comments New Form SCHEDULE 13G - GridAI Technologies Corp. Filed: 2026-01-13 AccNo: 0001213900-26-003817 Size: 14 KB Comment Full text
Ascendis Pharma (ASND) SEC News Jan. 13, 2026, 19:01 UTC 3 1 comments 📋 MIKKELSEN JAN MOLLER (Officer) plans to sell 87K shares of Ascendis Pharma A/S (at $211.99 each, total $18.4M) Filed: Jan 13, 2026 | ID: 000011 Comment Full text